Načítá se...

Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL

The hypothesis that raising high-density lipoprotein cholesterol (HDL-C) levels could improve the risk for cardiovascular disease (CVD) is facing challenges. There is multitudinous clear clinical evidence that the latest failures of HDL-C-raising drugs show no clear association with risks for CVD. A...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Peiqiu Cao, Haitao Pan, Tiancun Xiao, Ting Zhou, Jiao Guo, Zhengquan Su
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2015-07-01
Edice:International Journal of Molecular Sciences
Témata:
HDL
On-line přístup:http://www.mdpi.com/1422-0067/16/8/17245
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!